Literature DB >> 28025191

Fractional flow reserve to guide and to assess coronary artery bypass grafting.

Mariano Pellicano1,2, Bernard De Bruyne1, Gabor G Toth1,3, Filip Casselman1, William Wijns1,4, Emanuele Barbato1,2.   

Abstract

The aim of this review is to highlight the role of invasive functional evaluation in patients in whom coronary artery bypass graft (CABG) is indicated, and to examine the clinical evidence available in favour of fractional flow reserve (FFR) adoption in these patients, outline appropriate use, as well as point out potential pitfalls. FFR after CABG will also be reviewed, highlighting its correct interpretation and adoption when applied to both native coronary arteries and bypass grafts. Practice European guidelines support the use of FFR to complement coronary angiography with the highest degree of recommendation (Class IA) for the assessment of coronary stenosis before undertaking myocardial revascularization when previous non-invasive functional evaluation is unavailable or not conclusive. As a result, FFR has been adopted in routine clinical practice to guide clinicians decision as to whether or not perform a revascularization. Of note, due to the increasing confidence of the interventional cardiologists, FFR guidance is also being implemented to indicate or guide CABG. This is in anticipation of supportive clear-cut evidence, since recommendations for FFR adoption were based on randomized clinical trials investigating percutaneous coronary intervention (PCI) strategies in which patients with typical indications for CABG were excluded (e.g. left main disease, valvular disease, and coronary anatomy unsuitable for PCI). Based on the critical appraisal of the literature, FFR can play an important role in risk stratification and determining management strategy of patients either before or after CABG. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Coronary artery bypass graft ; Fractional flow reserve ; Left main coronary disease; Multivessel disease ; Revascularization

Mesh:

Year:  2017        PMID: 28025191     DOI: 10.1093/eurheartj/ehw505

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  Qualitative angiographic and quantitative myocardial perfusion assessment using fluorescent cardiac imaging during graded coronary artery bypass stenosis.

Authors:  Christian Detter; Detlef Russ; Jan Felix Kersten; Hermann Reichenspurner; Sabine Wipper
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-15       Impact factor: 2.357

2.  Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI).

Authors:  Gabor G Toth; Bernard De Bruyne; Petr Kala; Flavio L Ribichini; Filip Casselman; Ruben Ramos; Zsolt Piroth; Stephane Fournier; Carlos Van Mieghem; Martin Penicka; Martin Mates; Frank Van Praet; Ivan Degriek; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2018-07-19       Impact factor: 4.132

Review 3.  Fractional flow reserve to guide surgical coronary revascularization.

Authors:  Tara Shah; Joshua D Geleris; Ming Zhong; Rajesh V Swaminathan; Luke K Kim; Dmitriy N Feldman
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 4.  Understanding the predictive value and methods of risk assessment based on coronary computed tomographic angiography in populations with coronary artery disease: a review.

Authors:  Yiming Li; Kaiyu Jia; Yuheng Jia; Yong Yang; Yijun Yao; Mao Chen; Yong Peng
Journal:  Precis Clin Med       Date:  2021-07-26

Review 5.  Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions.

Authors:  Andreas Seraphim; Kristopher D Knott; Joao B Augusto; Katia Menacho; Sara Tyebally; Benjamin Dowsing; Sanjeev Bhattacharyya; Leon J Menezes; Daniel A Jones; Rakesh Uppal; James C Moon; Charlotte Manisty
Journal:  Front Cardiovasc Med       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.